02Jan 2018

FANCONI ANEMIA: FUTURE NEEDS AND QUESTIONING THE DEFINITION.

  • University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.
Crossref Cited-by Linking logo
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author
  1. Kee Y, D?Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia.J Clin Invest.2012;122:3799?3806.
  2. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia.?2002;297(5581):606?609.
  3. Alter BP. Cancer in Fanconi anemia, 1927-2001. 2003; 15;97:425-440.

[Alparslan Merdin. (2018); FANCONI ANEMIA: FUTURE NEEDS AND QUESTIONING THE DEFINITION. Int. J. of Adv. Res. 6 (1). 36] (ISSN 2320-5407). www.journalijar.com


AlparslanMerdin
University of Health Sciences,Ankara Dr. Abdurrahman YurtaslanOncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.

DOI:


Article DOI: 10.21474/IJAR01/6180       DOI URL: http://dx.doi.org/10.21474/IJAR01/6180


Share this article